Review
doi: 10.1016/j.coi.2006.09.013.
Epub 2006 Sep 28.
Immunoregulation by targeting T cells in the treatment of allergy and asthma
Affiliations
- PMID: 17010586
- DOI: 10.1016/j.coi.2006.09.013
Item in Clipboard
Review
Immunoregulation by targeting T cells in the treatment of allergy and asthma
Curr Opin Immunol.
2006 Dec.
Abstract
T-cell responses to allergens are crucial in determining the choice between health and disease. Th2 responses drive synthesis of IgE and the recruitment, maturation, survival and effector function of accessory cells such as eosinophils, basophils and mast cells. Allergen-specific strategies for targeting T-cell responses in established allergic diseases have been employed with success for almost a century. Recently, new insight into the mechanism of action of such approaches has revealed modulation of the delicate and complex regulatory mechanisms including suppression of Th2 responses through antagonistic Th1 responses and regulation through IL-10 and TGFbeta production.
Similar articles
-
Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more.Immunol Allergy Clin North Am. 2006 May;26(2):207-31, vi. doi: 10.1016/j.iac.2006.02.008. Immunol Allergy Clin North Am. 2006. PMID: 16701141 Review.
-
Mechanisms and treatment of allergic disease in the big picture of regulatory T cells.J Allergy Clin Immunol. 2009 Apr;123(4):735-46; quiz 747-8. doi: 10.1016/j.jaci.2009.02.030. J Allergy Clin Immunol. 2009. PMID: 19348912 Review.
-
Mechanisms of allergen-specific immunotherapy.J Allergy Clin Immunol. 2011 Jan;127(1):18-27; quiz 28-9. doi: 10.1016/j.jaci.2010.11.030. J Allergy Clin Immunol. 2011. PMID: 21211639 Review.
-
[Effector cells in allergy: biological principles and new pharmacologic concepts].Wien Klin Wochenschr. 1993;105(23):677-81. Wien Klin Wochenschr. 1993. PMID: 7508662 Review. German.
-
Targeting dendritic cells in allergen immunotherapy.Immunol Allergy Clin North Am. 2006 May;26(2):307-19, viii. doi: 10.1016/j.iac.2006.02.010. Immunol Allergy Clin North Am. 2006. PMID: 16701146 Review.
Cited by
-
Allergen immunotherapy for allergic respiratory diseases.Hum Vaccin Immunother. 2012 Oct;8(10):1499-512. doi: 10.4161/hv.21629. Epub 2012 Oct 1. Hum Vaccin Immunother. 2012. PMID: 23095870 Free PMC article. Review.
-
T-cell responses induced by allergen-specific immunotherapy.Clin Exp Immunol. 2010 Jul 1;161(1):10-8. doi: 10.1111/j.1365-2249.2010.04148.x. Epub 2010 Apr 9. Clin Exp Immunol. 2010. PMID: 20408857 Free PMC article. Review.
-
Sevoflurane Inhibits the Th2 Response and NLRP3 Expression in Murine Allergic Airway Inflammation.J Immunol Res. 2018 Sep 30;2018:9021037. doi: 10.1155/2018/9021037. eCollection 2018. J Immunol Res. 2018. PMID: 30363922 Free PMC article.
-
New directions in immunotherapy.Curr Allergy Asthma Rep. 2013 Apr;13(2):178-95. doi: 10.1007/s11882-012-0335-7. Curr Allergy Asthma Rep. 2013. PMID: 23315329 Review.
-
Oral Administration of MBG to Modulate Immune Responses and Suppress OVA-Sensitized Allergy in a Murine Model.Evid Based Complement Alternat Med. 2014;2014:567427. doi: 10.1155/2014/567427. Epub 2014 Mar 5. Evid Based Complement Alternat Med. 2014. PMID: 24723960 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
